Evidence map›Paper›PMID 30619116›Full record

ArticleFrontiers in microbiology2018

Inactivation of

Vitalij Novickij, Auksė Zinkevičienė, Ramunė Stanevičienė, Rūta Gruškienė, Elena Servienė, Iglė Vepštaitė-Monstavičė, Tatjana Krivorotova, Eglė Lastauskienė, Jolanta Sereikaitė, Irutė Girkontaitė and 1 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.8field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 26 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Vitalij NovickijInstitute of High Magnetic Fields, Vilnius Gediminas Technical University, Vilnius, Lithuania.
Auksė ZinkevičienėDepartment of Immunology, State Research Institute Centre for Innovative Medicine, Vilnius, Lithuania.
Ramunė StanevičienėLaboratory of Genetics, Nature Research Centre, Vilnius, Lithuania.
Rūta GruškienėDepartment of Chemistry and Bioengineering, Vilnius Gediminas Technical University, Vilnius, Lithuania.
Elena ServienėLaboratory of Genetics, Nature Research Centre, Vilnius, Lithuania.
Iglė Vepštaitė-MonstavičėLaboratory of Genetics, Nature Research Centre, Vilnius, Lithuania.
Tatjana KrivorotovaDepartment of Chemistry and Bioengineering, Vilnius Gediminas Technical University, Vilnius, Lithuania.
Eglė LastauskienėInstitute of Biosciences, Life Sciences Centre, Vilnius University, Vilnius, Lithuania.
Jolanta SereikaitėDepartment of Chemistry and Bioengineering, Vilnius Gediminas Technical University, Vilnius, Lithuania.
Irutė GirkontaitėDepartment of Immunology, State Research Institute Centre for Innovative Medicine, Vilnius, Lithuania.
Jurij NovickijInstitute of High Magnetic Fields, Vilnius Gediminas Technical University, Vilnius, Lithuania.
Vilnius Gediminas Technical University · LTNature Research Centre · LTState Research Institute Centre for Innovative Medicine · LTVilnius University · LT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nisin is a recognized bacteriocin widely used in food processing, however, being ineffective against gram-negative bacteria and in complex food systems. As a result, the research of methods that have cell wall-permeabilizing activity is required. In this study, electroporation to trigger sensitization of gram-negative bacteria to nisin-loaded pectin nanoparticles was used. As a model microorganism, bioluminescent strain of

Indexed as

antimicrobial resistancebacteria inactivationE. colielectroporationnisin

Identifiers

PMID30619116
PMCPMC6299027
OpenAlexW2904067211

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.